RSB Aurora 2025
News & Press

MIBio 2019: A Huge Success for RedShiftBio

Date: 
November 20, 2019

MMS technology is quickly becoming the go-to solution in biophysical characterization specialists' toolbox, replacing legacy techniques such as FTIR and CD as demonstrated by the response of the European biopharmaceutical industry to our technology at MiBio2019.

Want to Join Our Team?

Request a Demo Today! 

RedShiftBio AQS3 Product Detail